Diabetic retinopathy remains one of the leading causes of vision loss worldwide. This complication of diabetes affects...
Launching diabetic retinopathy screening in Chernihiv
read more
News
CheckEye expands access to diabetic retinopathy screening in Albania
As the year draws to a close, CheckEye continues to make strides in expanding its mission to provide accessible...
CheckEye receives Financial Support from the Business Bridge Project under Ukraine-Ready4EU
2024 has been a year of significant progress for CheckEye, as we continue our journey toward revolutionizing...
CheckEye joins the Top 100 Ukrainian rising startups for 2024
CheckEye has been recognized as one of the Top 100 Ukrainian Rising Startups for 2024—a major achievement that speaks...
The Ukrainian HealthTech startup CheckEye won the EIT Health InnoStars Awards 2024, becoming the first company from Ukraine to receive pan-European recognition in this competition
On November 27, 2024, a Ukrainian team made history by winning the prestigious EIT Health InnoStars Awards, thanks to...
CheckEye secures investment from Austria’s largest and most renowned pharmacy
Austria has become a strategic partner of the Ukrainian platform CheckEye, specializing in early diagnosis of chronic...
CheckEye joins the EBRD Star Venture Programme
We are proud to announce that CheckEye has been selected as one of the 10 high-potential startups to join the...
CheckEye: The first AI-based platform in Europe implementing a national chronic disease screening and complications program amid martial law
November 14, 2024, – On the occasion of World Diabetes Day, the CheckEye platform presents the results of its...
CheckEye at FUTURE FORCES FORUM 2024
The CheckEye team participated in FUTURE FORCES FORUM 2024 in Prague — one of the most influential international...